Real-time SEC alerts Start Free →
Profitelligence
Tilray Brands Inc.
TLRY HIGH Impact

Tilray Brands Inc.

Tilray Brands Faces Nasdaq Delisting Notice Due to Minimum Bid Price Non-Compliance

| 8-K |Healthcare

Summary

On March 25, 2025, Tilray Brands, Inc. received a notice from Nasdaq indicating it is not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Select Market. The company has 180 calendar days to regain compliance by maintaining a closing bid price of at least $1.00 per share for ten consecutive business days. Failure to comply within this period may result in delisting or transfer to the Nasdaq Capital Market.

Profitelligence Profitelligence Alerts

Get alerts for TLRY

Be first to know when Tilray Brands Inc. files with the SEC.

Set Up Alerts →

Filing Categories

Non-Compliance Notice Voluntary Delisting

Advertisement

About Tilray Brands Inc.

Tilray Brands Inc. is a pioneering player in the emerging global cannabis industry. A diversified company, it engages in the research, cultivation, production, and distribution of cannabis and hemp-based products. Tilray's primary function is to develop, produce, and distribute a wide range of medicinal and recreational cannabis products, including dried flower, extracts, and edibles. The company also produces hemp foods and alcoholic beverages. Founded in 2013, Tilray has rapidly gained a significant foothold, serving both medical patients and recreational consumers in multiple countries, including Canada, the United States, and parts of Europe. Tilray Brands Inc. operates within an industry that intersects with pharmaceuticals, consumer goods, and agriculture, heavily impacting sectors such as healthcare, wellness, and food and beverages. Through strategic acquisitions and partnerships, Tilray broadens its product offerings and global market presence. Its emphasis on research and innovation propels its market significance, especially as the demand for alternative wellness products grows. With the cannabis sector continuing to evolve, Tilray is poised as a key contributor to shaping market dynamics, establishing itself as a reputable brand committed to high-quality cannabis and cannabinoid-based products.

Exchange: NASDAQ Industry: Drug Manufacturers - Specialty & Generic Company Website →

Official SEC Documents

TLRY
TLRY Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement